Literature DB >> 19331201

Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer.

Linn Woelber1, Sven Mahner, Katharina Voelker, Christine Zu Eulenburg, Friederike Gieseking, Matthias Choschzick, Fritz Jaenicke, Joerg Schwarz.   

Abstract

BACKGROUND: Vulvar cancer is a rare disease and knowledge on prognostic factors is therefore limited and inconsistent. The aim of this study was to determine prognostic variables for recurrence and survival and to identify patterns of recurrence in patients with vulvar cancer. PATIENTS AND METHODS: All patients (n = 103) with primary vulvar cancer treated at the University Medical Center Hamburg-Eppendorf between 1996 and 2003 were retrospectively analysed regarding the prognostic relevance of different clinicopathological variables. Recurrences were evaluated with regard to their characteristics and localisation.
RESULTS: Age, lymph node metastasis, tumor size, depth of invasion and involvement of resection margins predicted poor disease-free and overall survival in univariate analysis. In multivariate analysis, lymph node status was the most important independent prognostic factor (p = 0.002). No correlation was observed between lymph node metastasis and localization of recurrent disease. Regardless of initial nodal involvement, recurrences occurred primarily in the vulvar region.
CONCLUSION: Inguinofemoral lymph node status at initial diagnosis is of critical prognostic importance for patients with vulvar cancer. Further tumour biological characteristics need to be identified to stratify patients with nodal involvement for adjuvant radiotherapy of the vulva to prevent local recurrences.

Entities:  

Mesh:

Year:  2009        PMID: 19331201

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  27 in total

1.  Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.

Authors:  Matthias Choschzick; Linn Woelber; Stephan Hess; Christine zu Eulenburg; Jörg Schwarz; Ronald Simon; Sven Mahner; Fritz Jaenicke; Volkmar Müller
Journal:  Virchows Arch       Date:  2010-04-01       Impact factor: 4.064

2.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

3.  Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma.

Authors:  André Mourão Lavorato-Rocha; Iara Sant'ana Rodrigues; Beatriz de Melo Maia; Mônica Maria Ágata Stiepcich; Glauco Baiocchi; Kátia Cândido Carvalho; Fernando Augusto Soares; José Vassallo; Rafael Malagoli Rocha
Journal:  Tumour Biol       Date:  2013-07-06

Review 4.  Recent trends in surgical and reconstructive management of vulvar cancer: review of literature.

Authors:  Salvatore Giovanni Vitale; Gaetano Valenti; Antonio Biondi; Diego Rossetti; Luigi Frigerio
Journal:  Updates Surg       Date:  2015-06-13

Review 5.  New Directions in Vulvar Cancer Pathology.

Authors:  Anthony Williams; Sheeba Syed; Shireen Velangi; Raji Ganesan
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

6.  Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer Unit.

Authors:  Masayuki Futagami; Yoshihito Yokoyama; Kaori Iino; Masahiko Aoki; Tadahiro Shoji; Toru Sugiyama; Hisanori Ariga; Hideki Tokunaga; Tadao Takano; Yoh Watanabe; Nobuo Yaegashi; Keiichi Jingu; Naoki Sato; Yukihiro Terada; Akira Anbai; Tsuyoshi Ohta; Hirohisa Kurachi; Yuuki Kuroda; Hiroshi Nishiyama; Keiya Fujimori; Takafumi Watanabe; Hisashi Sato; Toru Tase; Hitoshi Wada; Hideki Mizunuma
Journal:  Int J Clin Oncol       Date:  2015-02-24       Impact factor: 3.402

7.  Adjuvant Radiation in Early Stage Vulvar Cancer: A Review of Indications and Optimal Dose.

Authors:  Karishma Khullar; Tomas Patrich; Salma K Jabbour; Lara Hathout
Journal:  Appl Radiat Oncol       Date:  2022-03

8.  Primary mucinous adenocarcinoma of the vulva: A case report and review of the literature.

Authors:  Yanxia Sui; Junkai Zou; Nasra Batchu; Shulan Lv; Chao Sun; Jiang DU; Qing Wang; Qing Song; Qiling Li
Journal:  Mol Clin Oncol       Date:  2016-02-04

9.  Condyloma-like squamous cell carcinoma of the vulva: report of two midline cases.

Authors:  Shyam B Verma; Uwe Wollina
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-09-10

10.  Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva.

Authors:  Sara Iacoponi; Ignacio Zapardiel; Maria Dolores Diestro; Alicia Hernandez; Javier De Santiago
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.